Drug General Information
Drug ID	D06UYI
Former ID	DCL000037
Drug Name	AM103
Drug Type	Small molecular drug
Indication	Cardiovascular disorder [ICD10:I00-I99]		Discontinued in Phase 2	[548500]
Company	Amira Pharma.
Structure		Download 2D MOL 3D MOL
Formula	C22H20N4O3
PubChem Compound ID	56603665
Target and Pathway
Target(s)	Arachidonate 5-lipoxygenaseactivating protein	Target Info	Inhibitor	[550607]
NetPath Pathway	IL4 Signaling Pathway
	TGF_beta_Receptor Signaling Pathway
	Leptin Signaling Pathway
PANTHER Pathway	Inflammation mediated by chemokine and cytokine signaling pathway
WikiPathways	Nuclear Receptors Meta-Pathway
	Arachidonic acid metabolism
	Eicosanoid Synthesis
	Selenium Micronutrient Network
References
Ref 548500	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026047)
Ref 550607	AM103 Experimental Treatment for Respiratory Diseases. Amira Pharmaceuticals/GSK. 2009.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.